206265-17-0

Basic information

• Product Name: 6-[(4,6-diphenyl-2-pyridinyl)oxy]-2,2-dimethyl-1-hexylamine
• Synonyms: 6-[(4,6-diphenyl-2-pyridinyl)oxy]-2,2-dimethyl-1-hexylamine
• CAS NO: 206265-17-0
• Molecular Weight: 374.526
• Mol File: 206265-17-0.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 6-[(4,6-diphenyl-2-pyridinyl)oxy]-2,2-dimethyl-1-hexylamine(CAS DataBase Reference)
• NIST Chemistry Reference: 6-[(4,6-diphenyl-2-pyridinyl)oxy]-2,2-dimethyl-1-hexylamine(206265-17-0)
• EPA Substance Registry System: 6-[(4,6-diphenyl-2-pyridinyl)oxy]-2,2-dimethyl-1-hexylamine(206265-17-0)

Safety Data

• Hazardous Substances Data: 206265-17-0(Hazardous Substances Data)

Upstream product

• 2797-51-5 quinoclamine 
• 141747-91-3 2,2-dimethyl-6-[(4,6-diphenyl-pyridin-2-yl)oxy]hexanonitrile 
• 7647-14-5 sodium chloride 

Downstream Products

• 206266-97-9 3-amino-2-((tert-butoxy)-carbonylamino)-N-(6-(4,6-diphenyl(2-pyridyloxy))-2,2-dimethylhexyl)propanamide 
• 206263-69-6 N-(6-(4,6-diphenyl(2-pyridyloxy))-2,2-dimethylhexyl)-3-pyridylformamide 
• 206266-96-8 2-((tert-butoxy)carbonylamino)-N-(6-(4,6-diphenyl(2-pyridyloxy))-2,2-dimethylhexyl)-3-((fluoren-9-ylmethoxy)carbonylamino)propanamide 

Relevant articles and documents

Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation

The present invention provides novel diagnostic compositions comprising a radiolabeled LTB4 binding agent and a radiolabeled perfusion imaging agent, diagnostic kits comprising such compositions, and methods of concurrent imaging in a mammal comprising ad

Radiopharmaceuticals for imaging infection and inflammation

The present invention provides novel radiopharmaceuticals useful for the diagnosis of infection and inflammation, reagents and kits useful for preparing the radiopharmaceuticals, methods of imaging sites of infection and/or inflammation in a patient, and